ArticleThe Korean journal of hematology2012
Castleman disease.
Article in The Korean journal of hematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 47 citations in OpenAlex.
- Spinal Castleman disease: An imposter-A rare case from Ethiopia.Radiology case reports · 2026Article
- Radiological Imaging Findings of Adrenal Abnormalities in TAFRO Syndrome: A Systematic Review.Biomedicines · 2024Review
- Article
- Prevalence of Castleman's disease in patients suffering from cervical lymphadenopathy.Laryngoscope investigative otolaryngology · 2022Article
- Multicentric Castleman's disease of the lungs mimicking a multifocal adenocarcinoma.BMJ case reports · 2022Article
- A mesorectal incidentaloma: Rare localization of Castleman disease (Case report).Experimental and therapeutic medicine · 2022Article
- Castleman disease mimicking an adrenal tumor: A case report.Urology case reports · 2022Article
- A Rare Lymphoproliferative Disease: Castleman DiseaseTurkish journal of haematology : official journal of Turkish Society of Haematology · 2021Article
- Article
- Unicentric Castleman's disease in the female pelvis.Radiology case reports · 2020Article
- Article
- Detection of a unicentric type of Castleman-like mass at the site of adrenal grand: A case report and review of literature.World journal of clinical cases · 2018Article
- Activation and counteraction of antiviral innate immunity by KSHV: an Update.Science bulletin · 2018Article
- Role of Pattern Recognition Receptors in KSHV Infection.Cancers · 2018Review
- Pelvic Castleman's disease presenting as an adnexal tumor in a young woman.Obstetrics & gynecology science · 2015Article
- Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy.Thoracic cancer · 2014Article
- Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.Rare tumors · 2014Article
- Recurrent Inflammatory Flares in HIV-Infected Patients: Consider Castleman Disease!Journal of investigative medicine high impact case reportsArticle
- Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, IndiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Castleman and Towne described a disease presenting as a mediastinal mass resembling thymoma. It is also known as "giant lymph node hyperplasia", "lymph node hamartoma", "angiofollicular mediastinal lymph node hyperplasia", and "angiomatous lymphoid hyperplasia". The pathogenesis is unknown, but the bulk of evidence points toward faulty immune regulation, resulting in excessive B-lymphocyte and plasma-cell proliferation in lymphatic tissue. In addition to the mediastinal presentation, extrathoracic involvement in the neck, axilla, mesentery, pelvis, pancreas, adrenal gland, and retroperitoneum also have been described. There are 2 major pathologic variations of Castleman disease: (1) hyaline-vascular variant, the most frequent, characterized by small hyaline-vascular follicles and capillary proliferation; and (2) the plasma-cell variant, in which large lymphoid follicles are separated by sheets of plasma cells. The hyaline-vascular cases usually are largely asymptomatic, whereas the less common plasma-cell variant may present with fever, anemia, weight loss, and night sweats, along with polyclonal hypergamma-globulinemia. Castleman disease is a rare lymphoproliferative disorders. Few cases have been described world widely. In this article we reviewed the classification, pathogenesis, pathology, radiological features and up to date treatment with special emphasis on the role of viral stimulation, recent therapeutic modalities and the HIV-associated disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.